However, the company’s operating loss of $2.28 million was also an increase of 11.5 percent compared to 2012’s third quarter. The company’s operating expenses increased from $3.48 million in 2012 to $4.58 million in 2013.
More Articles on Devices:
NuVasive Q3 Income at $7k, Up Nearly 250% From Last Year
ArthroCare Profits Increase 4.27% in Q3
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
